ASSURANT, INC. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that ASSURANT, INC. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $12.81B | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $11.88B | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $11.13B | Feb 19, 2026 |
| FY2022 | Dec 31, 2022 | $2.65B | Feb 17, 2023 |
| FY2022 | Sep 30, 2022 | $2.55B | Feb 17, 2023 |
| FY2022 | Jun 30, 2022 | $2.51B | Feb 17, 2023 |
| FY2022 | Mar 31, 2022 | $2.48B | Feb 17, 2023 |
| FY2022 | Dec 31, 2021 | $2.57B | Feb 17, 2023 |
| FY2022 | Sep 30, 2021 | $2.64B | Feb 17, 2023 |
| FY2022 | Jun 30, 2021 | $2.54B | Feb 17, 2023 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $872.70M | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $760.20M | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $642.50M | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | $276.60M | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | $1.36B | Feb 15, 2024 |
| FY2022 | Dec 31, 2020 | $440.80M | Feb 17, 2023 |
| FY2021 | Dec 31, 2019 | $382.60M | Feb 22, 2022 |
| FY2018 | Dec 31, 2018 | $20.30M | Feb 22, 2019 |
| FY2018 | Sep 30, 2018 | $48.30M | Feb 22, 2019 |
| FY2018 | Jun 30, 2018 | $62.20M | Feb 22, 2019 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Dec 31, 2021 | $3.25B | Feb 17, 2023 |
| FY2022 | Dec 31, 2020 | $3.05B | Feb 17, 2023 |
| FY2021 | Dec 31, 2019 | $3.19B | Feb 22, 2022 |
| FY2020 | Dec 31, 2018 | $2.98B | Feb 19, 2021 |
| FY2019 | Dec 31, 2017 | $2.71B | Feb 19, 2020 |
| FY2018 | Dec 31, 2016 | $3.44B | Feb 22, 2019 |
| FY2017 | Dec 31, 2015 | $3.92B | Feb 14, 2018 |
| FY2016 | Dec 31, 2014 | $3.69B | Feb 14, 2017 |
| FY2015 | Dec 31, 2013 | $3.03B | Feb 16, 2016 |
| FY2014 | Dec 31, 2012 | $2.63B | Feb 19, 2015 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.83B | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $1.33B | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $1.14B | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | $596.90M | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | $781.70M | Feb 15, 2024 |
| FY2022 | Dec 31, 2020 | $1.34B | Feb 17, 2023 |
| FY2021 | Dec 31, 2019 | $1.41B | Feb 22, 2022 |
| FY2020 | Dec 31, 2018 | $656.70M | Feb 19, 2021 |
| FY2019 | Dec 31, 2017 | $530.40M | Feb 19, 2020 |
| FY2018 | Dec 31, 2016 | $108.60M | Feb 22, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $235.50M | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $221.30M | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $202.50M | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | $186.30M | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | $187.40M | Feb 15, 2024 |
| FY2022 | Dec 31, 2020 | $121.20M | Feb 17, 2023 |
| FY2021 | Dec 31, 2019 | $110.30M | Feb 22, 2022 |
| FY2020 | Dec 31, 2018 | $82.80M | Feb 19, 2021 |
| FY2019 | Dec 31, 2017 | $62.10M | Feb 19, 2020 |
| FY2018 | Dec 31, 2016 | $85.20M | Feb 22, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $36.29B | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $35.02B | Feb 19, 2026 |
| FY2024 | Dec 31, 2023 | $33.64B | Feb 20, 2025 |
| FY2023 | Dec 31, 2022 | $33.12B | Feb 15, 2024 |
| FY2022 | Dec 31, 2021 | $33.92B | Feb 17, 2023 |
| FY2021 | Dec 31, 2020 | $44.65B | Feb 22, 2022 |
| FY2020 | Dec 31, 2019 | $44.29B | Feb 19, 2021 |
| FY2019 | Dec 31, 2018 | $41.09B | Feb 19, 2020 |
| FY2018 | Dec 31, 2017 | $31.84B | Feb 22, 2019 |
| FY2017 | Dec 31, 2016 | $29.71B | Feb 14, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $30.42B | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $29.91B | Feb 19, 2026 |
| FY2024 | Dec 31, 2023 | $28.83B | Feb 20, 2025 |
| FY2023 | Dec 31, 2022 | $28.89B | Feb 15, 2024 |
| FY2022 | Dec 31, 2021 | $28.46B | Feb 17, 2023 |
| FY2021 | Dec 31, 2020 | $38.70B | Feb 22, 2022 |
| FY2020 | Dec 31, 2019 | $38.61B | Feb 19, 2021 |
| FY2019 | Dec 31, 2018 | $35.96B | Feb 19, 2020 |
| FY2018 | Dec 31, 2017 | $27.56B | Feb 22, 2019 |
| FY2017 | Dec 31, 2016 | $25.61B | Feb 14, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.87B | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $5.11B | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $4.81B | Feb 19, 2026 |
| FY2025 | Dec 31, 2022 | $4.23B | Feb 19, 2026 |
| FY2024 | Dec 31, 2021 | $5.46B | Feb 20, 2025 |
| FY2021 | Dec 31, 2020 | $5.95B | Feb 22, 2022 |
| FY2020 | Dec 31, 2019 | $5.65B | Feb 19, 2021 |
| FY2019 | Dec 31, 2018 | $5.11B | Feb 19, 2020 |
| FY2018 | Dec 31, 2017 | $4.27B | Feb 22, 2019 |
| FY2017 | Dec 31, 2016 | $4.10B | Feb 14, 2018 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.65B | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $2.62B | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $2.61B | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | $2.60B | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | $2.57B | Feb 15, 2024 |
| FY2022 | Dec 31, 2020 | $2.59B | Feb 17, 2023 |
| FY2021 | Dec 31, 2019 | $2.21B | Feb 22, 2022 |
| FY2020 | Dec 31, 2018 | $2.32B | Feb 19, 2021 |
| FY2019 | Dec 31, 2017 | $917.70M | Feb 19, 2020 |
| FY2018 | Dec 31, 2016 | $830.90M | Feb 22, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.83B | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $4.38B | Feb 19, 2026 |
| FY2024 | Dec 31, 2023 | $4.03B | Feb 20, 2025 |
| FY2023 | Dec 31, 2022 | $3.70B | Feb 15, 2024 |
| FY2022 | Dec 31, 2021 | $4.04B | Feb 17, 2023 |
| FY2021 | Dec 31, 2020 | $3.55B | Feb 22, 2022 |
| FY2020 | Dec 31, 2019 | $5.97B | Feb 19, 2021 |
| FY2019 | Dec 31, 2018 | $5.76B | Feb 19, 2020 |
| FY2018 | Dec 31, 2017 | $5.70B | Feb 22, 2019 |
| FY2017 | Dec 31, 2016 | $5.30B | Feb 14, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.83B | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $1.81B | Feb 19, 2026 |
| FY2024 | Dec 31, 2023 | $1.63B | Feb 20, 2025 |
| FY2023 | Dec 31, 2022 | $1.54B | Feb 15, 2024 |
| FY2022 | Dec 31, 2021 | $2.04B | Feb 17, 2023 |
| FY2021 | Dec 31, 2020 | $2.21B | Feb 22, 2022 |
| FY2020 | Dec 31, 2019 | $1.87B | Feb 19, 2021 |
| FY2019 | Dec 31, 2018 | $1.25B | Feb 19, 2020 |
| FY2018 | Dec 31, 2017 | $996.80M | Feb 22, 2019 |
| FY2018 | Dec 31, 2016 | $1.03B | Feb 22, 2019 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2019 | Dec 31, 2019 | $2.01B | Feb 19, 2020 |
| FY2019 | Dec 31, 2018 | $2.01B | Feb 19, 2020 |
| FY2018 | Dec 31, 2017 | $1.07B | Feb 22, 2019 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 17 | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | 14 | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | 12 | Feb 19, 2026 |
| FY2022 | Dec 31, 2022 | 1 | Feb 17, 2023 |
| FY2022 | Sep 30, 2022 | 0 | Feb 17, 2023 |
| FY2022 | Jun 30, 2022 | 0 | Feb 17, 2023 |
| FY2022 | Mar 31, 2022 | 2 | Feb 17, 2023 |
| FY2022 | Dec 31, 2021 | 2 | Feb 17, 2023 |
| FY2022 | Sep 30, 2021 | 14 | Feb 17, 2023 |
| FY2022 | Jun 30, 2021 | 3 | Feb 17, 2023 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 16 | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | 14 | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | 11 | Feb 19, 2026 |
| FY2022 | Dec 31, 2022 | 1 | Feb 17, 2023 |
| FY2022 | Sep 30, 2022 | 0 | Feb 17, 2023 |
| FY2022 | Jun 30, 2022 | 0 | Feb 17, 2023 |
| FY2022 | Mar 31, 2022 | 2 | Feb 17, 2023 |
| FY2022 | Dec 31, 2021 | 2 | Feb 17, 2023 |
| FY2022 | Sep 30, 2021 | 14 | Feb 17, 2023 |
| FY2022 | Jun 30, 2021 | 3 | Feb 17, 2023 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 49.79M | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | 50.83M | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | 51.96M | Feb 19, 2026 |
| FY2025 | Dec 31, 2022 | 52.83M | Feb 19, 2026 |
| FY2024 | Dec 31, 2021 | 55.75M | Feb 20, 2025 |
| FY2023 | Dec 31, 2020 | 57.97M | Feb 15, 2024 |
| FY2022 | Dec 31, 2019 | 59.95M | Feb 17, 2023 |
| FY2021 | Dec 31, 2018 | 61.91M | Feb 22, 2022 |
| FY2020 | Dec 31, 2017 | 52.42M | Feb 19, 2021 |
| FY2019 | Dec 31, 2016 | 55.94M | Feb 19, 2020 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $168.40M | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $155.90M | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $152.30M | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | $150.20M | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | $157.60M | Feb 15, 2024 |
| FY2022 | Dec 31, 2020 | $154.60M | Feb 17, 2023 |
| FY2021 | Dec 31, 2019 | $151.40M | Feb 22, 2022 |
| FY2020 | Dec 31, 2018 | $133.80M | Feb 19, 2021 |
| FY2019 | Dec 31, 2017 | $119.00M | Feb 19, 2020 |
| FY2018 | Dec 31, 2016 | $125.30M | Feb 22, 2019 |